3/2
07:30 am
zvra
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
Medium
Report
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
2/25
12:31 pm
zvra
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential? [Yahoo! Finance]
2/25
07:30 am
zvra
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
Low
Report
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
2/18
01:51 pm
zvra
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Low
Report
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
2/4
08:29 am
zvra
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™ [Yahoo! Finance]
Medium
Report
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™ [Yahoo! Finance]
2/4
07:30 am
zvra
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
Low
Report
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
2/2
07:41 am
zvra
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026 [Yahoo! Finance]
Medium
Report
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026 [Yahoo! Finance]
2/2
07:30 am
zvra
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
Medium
Report
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
1/26
07:30 am
zvra
Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
Low
Report
Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
1/24
07:11 pm
zvra
Investing in Zevra Therapeutics (NASDAQ:ZVRA) three years ago would have delivered you a 63% gain [Yahoo! Finance]
Low
Report
Investing in Zevra Therapeutics (NASDAQ:ZVRA) three years ago would have delivered you a 63% gain [Yahoo! Finance]
1/13
04:06 am
zvra
Zevra Therapeutics (NASDAQ:ZVRA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Zevra Therapeutics (NASDAQ:ZVRA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
1/8
07:30 am
zvra
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
Low
Report
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
1/3
07:27 am
zvra
Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market [Seeking Alpha]
Medium
Report
Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market [Seeking Alpha]
12/30
09:08 am
zvra
Zevra Therapeutics (NASDAQ:ZVRA) was given a new $26.00 price target on by analysts at HC Wainwright.
Low
Report
Zevra Therapeutics (NASDAQ:ZVRA) was given a new $26.00 price target on by analysts at HC Wainwright.
12/29
07:30 am
zvra
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
Low
Report
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
12/14
05:24 am
zvra
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? [Yahoo! Finance]
12/14
03:09 am
zvra
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? [Yahoo! Finance]
12/12
04:30 pm
zvra
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)